Treatment with recombinant trichinella spiralis cathepsin B-like protein ameliorates intestinal ischemia/reperfusion injury in mice by promoting a switch from M1 to M2 macrophages

Journal of Immunology

Volumn 195, Issue 1, 2015, Pages 317-328

  Liu, Wei Feng ^a   Wen, Shi Hong ^a   Zhan, Jian Hua ^b   Li, Yun Sheng ^a   Shen, Jian Tong ^a   Yang, Wen Jing ^a   Zhou, Xing Wang ^a   Liu, Ke Xuan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CHEMOKINE RECEPTOR CCR7; CYTOKINE; FOUND IN INFLAMMATORY ZONE PROTEIN 1; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; PROTEIN INHIBITOR; RECOMBINANT PROTEIN; RECOMBINANT TRICHINELLA SPIRALIS CATHEPSIN B LIKE PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG; 4-(BENZYLAMINO)-2-((2-(3-CHLORO-4-HYDROXYPHENYL)ETHYL)AMINO)PYRIMIDINE-5-CARBOXAMIDE; ARG1 PROTEIN, MOUSE; ARGINASE; CATHEPSIN B; CCR7 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; PARASITE ANTIGEN; PYRIMIDINE DERIVATIVE; STAT6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; FOOD INTAKE; INTESTINE FUNCTION; INTESTINE ISCHEMIA; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SURVIVAL RATE; TREATMENT OUTCOME; WEIGHT GAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE; MACROPHAGE ACTIVATION; MORTALITY; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL; TRICHINELLA SPIRALIS; VACCINATION;

ANIMALS; ANTIGENS, HELMINTH; ARGINASE; CATHEPSIN B; GENE EXPRESSION REGULATION; INTESTINES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; PYRIMIDINES; RECEPTORS, CCR7; RECOMBINANT PROTEINS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; SURVIVAL ANALYSIS; TRICHINELLA SPIRALIS; VACCINATION;

EID: 84932135495     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401864     Document Type: Article

References (62)

1. Mallick, I. H., W. Yang, M. C. Winslet, and A. M. Seifalian. 2004. Ischemiareperfusion injury of the intestine and protective strategies against injury. Dig. Dis. Sci. 49: 1359-1377.
2. Martin, B. 2007. Prevention of gastrointestinal complications in the critically ill patient. AACN Adv. Crit. Care 18: 158-166.
3. Köhler, H. F., I. M. DeLucca, and L. Sbragia Neto. 2011. Enteral antioxidants in ischemia/reperfusion injuries in rats. Rev. Col. Bras. Cir. 38: 422-428.
4. Fleming, S. D., and G. C. Tsokos. 2006. Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun. Rev. 5: 89-92.
5. Zuidema, M. Y., and C. Zhang. 2010. Ischemia/reperfusion injury: The role of immune cells. World J Cardiol 2: 325-332.
6. Linfert, D., T. Chowdhry, and H. Rabb. 2009. Lymphocytes and ischemiareperfusion injury. Transplant. Rev. (Orlando) 23: 1-10.
7. Lee, H., D. J. Green, L. Lai, Y. J. Hou, J. C. Jensenius, D. Liu, C. Cheong, C. G. Park, and M. Zhang. 2010. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol. Immunol. 47: 972-981.
8. Prakash, A., K. R. Mesa, K. Wilhelmsen, F. Xu, J. M. Dodd-o, and J. Hellman. 2012. Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice. Anesthesiology 117: 822-835.
9. Gao, X. M., Y. Liu, D. White, Y. Su, B. G. Drew, C. R. Bruce, H. Kiriazis, Q. Xu, N. Jennings, A. Bobik, et al. 2011. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J. Mol. Cell. Cardiol. 50: 991-999.
10. Devey, L., D. Ferenbach, E. Mohr, K. Sangster, C. O. Bellamy, J. Hughes, and S. J. Wigmore. 2009. Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. Mol. Ther. 17: 65-72.
11. Lu, L., S. Faubel, Z. He, A. Andres Hernando, A. Jani, R. Kedl, and C. L. Edelstein. 2012. Depletion of macrophages and dendritic cells in ischemic acute kidney injury. Am. J. Nephrol. 35: 181-190.
12. Chen, Y., V. C. Lui, N. V. Rooijen, and P. K. Tam. 2004. Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut. Gut 53: 1772-1780.
13. Schaefer, N., K. Tahara, J. Schmidt, S. Wehner, J. C. Kalff, K. Abu-Elmagd, A. Hirner, and A. Türler. 2007. Resident macrophages are involved in intestinal transplantation-associated inflammation and motoric dysfunction of the graft muscularis. Am. J. Transplant. 7: 1062-1070.
14. Van Ginderachter, J. A., K. Movahedi, G. Hassanzadeh Ghassabeh, S. Meerschaut, A. Beschin, G. Raes, and P. De Baetselier. 2006. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 211: 487-501.
15. Martinez, F. O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27: 451-483.
16. Cassetta, L., E. Cassol, and G. Poli. 2011. Macrophage polarization in health and disease. ScientificWorldJournal 11: 2391-2402.
17. Lee, S., S. Huen, H. Nishio, S. Nishio, H. K. Lee, B. S. Choi, C. Ruhrberg, and L. G. Cantley. 2011. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22: 317-326.
18. Radford-Smith, G. L. 2005. Will worms really cure Crohn's disease? Gut 54: 6-8.
19. Summers, R. W., D. E. Elliott, J. F. Urban, Jr., R. A. Thompson, and J. V. Weinstock. 2005. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128: 825-832.
20. McInnes, I. B., B. P. Leung, M. Harnett, J. A. Gracie, F. Y. Liew, and W. Harnett. 2003. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J. Immunol. 171: 2127-2133.
21. Correale, J., and M. Farez. 2007. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 61: 97-108.
22. Feary, J., J. Britton, and J. Leonardi-Bee. 2011. Atopy and current intestinal parasite infection: a systematic review and meta-analysis. Allergy 66: 569-578.
23. Reyes, J. L., and L. I. Terrazas. 2007. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol. 29: 609-619.
24. Du, L., H. Tang, Z. Ma, J. Xu, W. Gao, J. Chen, W. Gan, Z. Zhang, X. Yu, X. Zhou, and X. Hu. 2011. The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice. Dig. Dis. Sci. 56: 2810-2817.
25. Du, L., H.Wei, L. Li, H. Shan, Y. Yu, Y. Wang, and G. Zhang. 2014. Regulation of recombinant Trichinella spiralis 53-kDa protein (rTsP53) on alternatively activated macrophages via STAT6 but not IL-4Ra in vitro. Cell. Immunol. 288: 1-7.
26. Zhan, J. H., J. P. Yao, W. Liu, X. C. Hu, Z. D. Wu, and X. W. Zhou. 2013. Analysis of a novel cathepsin B circulating antigen and its response to drug treatment in Trichinella-infected mice. Parasitol. Res. 112: 3213-3222.
27. Zhou, J., W. Q. Huang, C. Li, G. Y. Wu, Y. S. Li, S. H. Wen, W. L. Lei, and K. X. Liu. 2012. Intestinal ischemia/reperfusion enhances microglial activation and induces cerebral injury and memory dysfunction in rats. Crit. Care Med. 40: 2438-2448.
28. Dong, W., F. Li, Z. Pan, S. Liu, H. Yu, X. Wang, S. Bi, and W. Zhang. 2013. Resveratrol ameliorates subacute intestinal ischemia-reperfusion injury. J. Surg. Res. 185: 182-189.
29. Kabay, B., F. O. Aytekin, C. Aydin, A. Ozer, N. Kabay, K. Tekin, U. Sungurtekin, E. Erdem, and A. Ozden. 2005. Interleukin-10 gene therapy attenuates pulmonary tissue injury caused by mesenteric ischemia-reperfusion in a mouse model. Tohoku J. Exp. Med. 207: 133-142.
30. Chiba, Y., M. Todoroki, Y. Nishida, M. Tanabe, and M. Misawa. 2009. A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice. Am. J. Respir. Cell Mol. Biol. 41: 516-524.
31. Chiu, C. J., A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 101: 478-483.
32. Schmittgen, T. D., B. A. Zakrajsek, A. G. Mills, V. Gorn, M. J. Singer, and M. W. Reed. 2000. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285: 194-204.
33. Kimizuka, K., A. Nakao, M. A. Nalesnik, A. J. Demetris, T. Uchiyama, K. Ruppert, M. P. Fink, D. B. Stolz, and N. Murase. 2004. Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation. Am. J. Transplant. 4: 482-494.
34. Davis, M. J., T. M. Tsang, Y. Qiu, J. K. Dayrit, J. B. Freij, G. B. Huffnagle, and M. A. Olszewski. 2013. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio 4: e00264-e13.
35. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
36. Biswas, S. K., and A. Mantovani. 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11: 889-896.
37. Desestret, V., A. Riou, F. Chauveau, T. H. Cho, E. Devillard, M. Marinescu, R. Ferrera, C. Rey, M. Chanal, D. Angoulvant, et al. 2013. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS ONE 8: e67063.
38. Zhou, X., Y. C. Luo, W. J. Ji, L. Zhang, Y. Dong, L. Ge, R. Y. Lu, H. Y. Sun, Z. Z. Guo, G. H. Yang, et al. 2013. Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats. PLoS ONE 8: e74390.
39. Cuzzocrea, S., P. K. Chatterjee, E.Mazzon, L. Dugo, A. De Sarro, F. A. Van de Loo, A. P. Caputi, and C. Thiemermann. 2002. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 18: 169-176.
40. Liu, K. X., T. Rinne, W. He, F. Wang, and Z. Xia. 2007. Propofol attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat. Can. J. Anaesth. 54: 366-374.
41. Barocelli, E., V. Ballabeni, P. Ghizzardi, F. Cattaruzza, S. Bertoni, C. A. Lagrasta, and M. Impicciatore. 2006. The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide 14: 212-218.
42. Takizawa, Y., T. Kitazato, H. Ishizaka, N. Kamiya, M. Tomita, and M. Hayashi. 2011. Effect of aminoguanidine on ischemia/reperfusion injury in rat small intestine. Biol. Pharm. Bull. 34: 1737-1743.
43. Stewart, G. L., B. Wood, and R. B. Boley. 1985. Modulation of host response by Trichinella pseudospiralis. Parasite Immunol. 7: 223-233.
44. Witte, M. B., and A. Barbul. 2003. Arginine physiology and its implication for wound healing. Wound Repair Regen. 11: 419-423.
45. Little, M. C., R. J. Hurst, and K. J. Else. 2014. Dynamic changes in macrophage activation and proliferation during the development and resolution of intestinal inflammation. J. Immunol. 193: 4684-4695.
46. Little, M. C., L. V. Bell, L. J. Cliffe, and K. J. Else. 2005. The characterization of intraepithelial lymphocytes, lamina propria leukocytes, and isolated lymphoid follicles in the large intestine of mice infected with the intestinal nematode parasite Trichuris muris. J. Immunol. 175: 6713-6722.
47. Albanesi, C., H. R. Fairchild, S. Madonna, C. Scarponi, O. De Pità, D. Y. Leung, and M. D. Howell. 2007. IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J. Immunol. 179: 984-992.
48. Zhu, J., Z. Xu, X. Chen, S. Zhou, W. Zhang, Y. Chi, W. Li, X. Song, F. Liu, and C. Su. 2014. Parasitic antigens alter macrophage polarization during Schistosoma japonicum infection in mice. Parasit Vectors 7: 122.
49. Stütz, A. M., L. A. Pickart, A. Trifilieff, T. Baumruker, E. Prieschl-Strassmayr, and M. Woisetschläger. 2003. The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J. Immunol. 170: 1789-1796.
50. Chiba, Y., M. Todoroki, and M. Misawa. 2010. Interleukin-4 upregulates RhoA protein via an activation of STAT6 in cultured human bronchial smooth muscle cells. Pharmacol. Res. 61: 188-192.
51. Wang, W., N. Smail, P. Wang, and I. H. Chaudry. 1998. Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6. J. Surg. Res. 79: 39-46.
52. Wehner, S., N. T. Schwarz, R. Hundsdoerfer, C. Hierholzer, D. J. Tweardy, T. R. Billiar, A. J. Bauer, and J. C. Kalff. 2005. Induction of IL-6 within the rodent intestinal muscularis after intestinal surgical stress. Surgery 137: 436-446.
53. Liu, K. X., Y. S. Li, W. Q. Huang, S. Q. Chen, Z. X. Wang, J. X. Liu, and Z. Xia. 2009. Immediate postconditioning during reperfusion attenuates intestinal injury. Intensive Care Med. 35: 933-942.
54. Rollwagen, F. M., S. Madhavan, A. Singh, Y. Y. Li, K. Wolcott, and R. Maheshwari. 2006. IL-6 protects enterocytes from hypoxia-induced apoptosis by induction of bcl-2 mRNA and reduction of fas mRNA. Biochem. Biophys. Res. Commun. 347: 1094-1098.
55. Jin, X., T. A. Zimmers, Z. Zhang, R. H. Pierce, and L. G. Koniaris. 2010. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 59: 186-196.
56. Fukatsu, K., K. Tanabe, Y. Maeshima, J. Omata, H. Yasuhara, and D. Saitoh. 2010. Neutrophil elastase inhibitor restores gut ischemia reperfusion-induced impairment of gut immunity with reduced plasma interleukin-6 concentrations in mice. Surg. Infect. (Larchmt) 11: 517-522.
57. Souza, D. G., A. C. Soares, V. Pinho, H. Torloni, L. F. Reis, M. M. Teixeira, and A. A. Dias. 2002. Increased mortality and inflammation in tumor necrosis factorstimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am. J. Pathol. 160: 1755-1765.
58. Stringa, P., N. Lausada, D. Romanin, M. Machuca, A. Cabanne, M. Rumbo, and G. Gondolesi. 2012. Defining the nonreturn time for intestinal ischemia reperfusion injury in mice. Transplant. Proc. 44: 1214-1217.
59. Watson, M. J., B. Ke, X. D. Shen, F. Gao, R. W. Busuttil, J. W. Kupiec-Weglinski, and D. G. Farmer. 2012. Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice. Surgery 152: 843-850.
60. Goodridge, H. S., F. A. Marshall, K. J. Else, K. M. Houston, C. Egan, L. Al-Riyami, F. Y. Liew, W. Harnett, and M. M. Harnett. 2005. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J. Immunol. 174: 284-293.
61. Kane, C. M., L. Cervi, J. Sun, A. S. McKee, K. S. Masek, S. Shapira, C. A. Hunter, and E. J. Pearce. 2004. Helminth antigens modulate TLR-initiated dendritic cell activation. J. Immunol. 173: 7454-7461.
62. Li, L., and M. D. Okusa. 2010. Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin. Nephrol. 30: 268-277.